Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53
- 29 July 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 333 (2), 396-403
- https://doi.org/10.1016/j.bbrc.2005.04.176
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cellsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1999
- Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23Oncogene, 1998
- The plurifunctional nucleolusNucleic Acids Research, 1998
- Telomeres, the nucleolus and agingCurrent Opinion in Cell Biology, 1998
- Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cellsOncogene, 1998
- Cloning and Functional Analysis of the Promoter for KDR/flk-1, a Receptor for Vascular Endothelial Growth FactorPublished by Elsevier ,1995
- Putative nuclear localization signals (NLS) in protein transcription factorsJournal of Cellular Biochemistry, 1994
- Immunolocalization of phosphoprotein B23 in proliferating and non‐proliferating hela cellsInternational Journal of Cancer, 1990
- Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growthBiochemistry, 1989
- The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody.The Journal of cell biology, 1988